| scholarly article | Q13442814 |
| P2093 | author name string | Gibson JA | |
| Gilleland LB | |||
| Champlin FR | |||
| Gilleland HE | |||
| P433 | issue | 1 | |
| P921 | main subject | Pseudomonas aeruginosa | Q31856 |
| P304 | page(s) | 41-50 | |
| P577 | publication date | 1989-05-01 | |
| P1433 | published in | Journal of Medical Microbiology | Q15708716 |
| P1476 | title | Adaptive resistance to aminoglycoside antibiotics in Pseudomonas aeruginosa. | |
| P478 | volume | 29 |
| Q39881843 | Adaptive resistance following single doses of gentamicin in a dynamic in vitro model. |
| Q38814607 | Adaptive resistance to antibiotics in bacteria: a systems biology perspective |
| Q44029907 | Adaptive resistance to benzalkonium chloride, amikacin and tobramycin: the effect on susceptibility to other antimicrobials |
| Q34277787 | Aminoglycoside adaptive resistance: importance for effective dosage regimens |
| Q36021296 | Aminoglycoside resistance in Pseudomonas aeruginosa |
| Q95806228 | Aminoglycosides--50 years on |
| Q72257268 | Aminoglycosides: the complex problem of antibiotic mechanisms and clinical applications |
| Q34631472 | Biofilms in vitro and in vivo: do singular mechanisms imply cross-resistance? |
| Q91811515 | Complete Killing of Agar Lawn Biofilms by Systematic Spacing of Antibiotic-Loaded Calcium Sulfate Beads |
| Q54062491 | Demonstration of a fusion mechanism between a fluid bactericidal liposomal formulation and bacterial cells. |
| Q35926193 | Dynamic Proteome Response of Pseudomonas aeruginosa to Tobramycin Antibiotic Treatment |
| Q44041308 | Efficacy and tolerability of extended-interval aminoglycoside administration in pediatric patients. |
| Q91782238 | Hydrogels Embedded With Melittin and Tobramycin Are Effective Against Pseudomonas aeruginosa Biofilms in an Animal Wound Model |
| Q35124853 | In vitro characterization of aminoglycoside adaptive resistance in Pseudomonas aeruginosa. |
| Q79185972 | Mechanism of adaptive resistance to aminoglycosides of Pseudomonas aeruginosa |
| Q74746286 | Mechanisms of antibiotic resistance in Pseudomonas aeruginosa |
| Q39743310 | MexXY-OprM efflux pump is necessary for a adaptive resistance of Pseudomonas aeruginosa to aminoglycosides. |
| Q28276967 | Morphological and ultrastructural changes in bacterial cells as an indicator of antibacterial mechanism of action |
| Q38051316 | Once daily dosing of aminoglycosides in pediatric cystic fibrosis patients: a review of the literature |
| Q33928699 | Once-daily dosing of aminoglycoside antibiotics |
| Q37697773 | Once-daily gentamicin dosing in pediatric patients without cystic fibrosis |
| Q44867857 | Pharmacokinetics of tobramycin following intravenous, intramuscular, and intra-articular administration in healthy horses |
| Q40949882 | Preclinical and clinical evaluation of once-daily aminoglycoside chemotherapy |
| Q34023671 | Programmed death in bacteria |
| Q35138044 | Rationale behind high-dose amoxicillin therapy for acute otitis media due to penicillin-nonsusceptible pneumococci: support from in vitro pharmacodynamic studies. |
| Q54279748 | The patterns and transmissibility of antibiotic resistance among clinical strains of Pseudomonas aeruginosa |
| Q88376487 | Triclosan Is an Aminoglycoside Adjuvant for Eradication of Pseudomonas aeruginosa Biofilms |
| Q52881617 | What is the evidence for once-daily aminoglycoside therapy? |
| Q64963086 | YhjX Regulates the Growth of Escherichia coli in the Presence of a Subinhibitory Concentration of Gentamicin and Mediates the Adaptive Resistance to Gentamicin. |
Search more.